SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Shanghai Junshi Biosciences Receives Supplemental Drug Approval

China's NMPA granted Shanghai Junshi Biosciences a supplemental drug approval.

SquawkNews Desk 3 updates Updated Oct 28, 2026, 01:50 PM UTC

Story updates

01:50:34 PM UTC
SquawkNews
SHANGHAI JUNSHI BIOSCIENCES - APPROVAL GRANTED FOR TORIPALIMAB AS MONOTHERAPY FOR ADVANCED UROTHELIA
01:50:44 PM UTC
SquawkNews
China Grants Regular Approval to Junshi Biosciences’ Toripalimab for Previously Treated Urothelial C
01:50:48 PM UTC
SquawkNews
Junshi Biosciences erhält reguläre Zulassung in China für Toripalimab bei fortgeschrittenem Urothelk

Related stories

FDA Clears IND for Phase 2 VT-7208 Study in Chronic Spontaneous Urticaria The U.S. FDA cleared an investigational new drug application for a Phase 2 study of VT-7208 in chronic spontaneous urticaria. M impact | REGULATION | Oct 29, 2026, 12:03 PM UTC Pakistan Court Jails Rights Couple for 10 Years, Family Says A Pakistani court sentenced a prominent rights couple to 10 years in prison, according to their family. M impact | REGULATION | Oct 29, 2026, 11:49 AM UTC MYEG Unit Faces RM 353.13 Million Tax Claim MYEG’s wholly owned subsidiary Zetrix Ai faces a RM 353.13 million tax claim. M impact | REGULATION | Oct 29, 2026, 11:40 AM UTC Utah Files Criminal Charges Against Kalshi Over Sports Betting Utah accused Kalshi of promoting illegal sports betting. M impact | REGULATION | Oct 29, 2026, 11:37 AM UTC Hong Kong housing chief resigns over Tai Po fire Hong Kong’s housing chief resigned, taking political responsibility for the Tai Po fire. The government is also introducing reforms to combat bid-rigging. M impact | REGULATION | Oct 29, 2026, 11:24 AM UTC China’s Communist Party approves expulsion of 33 officials China’s Communist Party approved the expulsion of 33 officials, Reuters reported. M impact | REGULATION | Oct 29, 2026, 11:17 AM UTC